Renee Lentini insider trades: ImmunoGen (IMGN) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Renee reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 5, 2024 | IMGN | ↓ Sell | 2,631 | $29.30 | $77K | Direct | Feb 6, 2024 (1d) |
| Dec 26, 2023 | IMGN | ↓ Sell | 6,548 | $29.74 | $195K | Direct | Dec 27, 2023 (1d) |
| Nov 6, 2023 | IMGN | ↓ Sell | 219,545 | $15.29 | $3.4M | Direct | Nov 8, 2023 (2d) |
| Aug 2, 2023 | IMGN | ↓ Sell | 148,277 | $17.55 | $2.6M | Direct | Aug 4, 2023 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Renee Lentini's insider trades
Renee Lentini is VP & Prin Acctg Officer at ImmunoGen (IMGN). Since Aug 2, 2023, Renee has reported no open-market purchases and 4 sales worth $6.2M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (12 filings), option exercises (5 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IMGN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.